Brought to you by 
Sensus Healthcare's IPO nets $11.8mm
Jun 2016
Executive Summary
Sensus Healthcare Inc. (noninvasive skin cancer treatment) netted $11.8mm through its initial public offering of 2.3mm common shares (including the overallotment) at $5.50. Investors also received three-year warrants to buy 2.3mm shares at $6.75. The company originally intended to sell 1.8mm shares at $10-12 when it first set a range in March, but then modified the S-1 filing to reflect a new range of 1.75mm shares at $6.25 a month before closing the offering.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com